301-325-3654

410-333-6792

World Trade Center Building 401 E. Pratt Street Baltimore, MD 21202

MIDC

Maryland Israel Development Center

BioCancell and the University of Maryland Medical Center – Conduct Clinical Trials

Home » Portfolio » BioCancell and the University of Maryland Medical Center – Conduct Clinical Trials
BioCancell, developers of cancer diagnostics, participated in the
MIDC’s MarketReach America™ program. The MIDC introduced
them to physicians at the University of Maryland Medical Center
who conducted clinical trials for BioCancell to submit to the FDA for
approval. BioCancell and the University of Maryland received a BIRD
Foundation grant for the clinical trials.
Related Portfolio

HemaClear of Israel – Meet Potential Customers

The MIDC introduced HemaClear, developers of specialized bandages for emergency medicine to hospitals throughout Maryland and received order from four hospitals.

Elta North America – Open a U.S. Office

GOVERNOR OF MARYLAND, ISRAELI AMBASSADOR, SENATOR AND OTHER OFFICIALS CELEBRATE THE GRAND OPENING OF ELTA NORTH AMERICA IN FULTON, MD

RadiFlow and Patriot Technologies – Fund Joint R&D Projects

Patriot Technologies and RADiFlow Receive Grant for the Development of Secure Smart Grid Automation Communication Solution

Subscribe to Newsletter

Sign up here.
↑ Top of Page